Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Esteller

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Oncogene|November 7, 2018
Correction: CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancerA Lujambio, A Portela, J Liz, et al.
Oncogene|September 6, 2016
Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogrammingO A Romero, S Verdura, M Torres-Diz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
K-ras and p16 aberrations confer poor prognosis in human colorectal cancerM Esteller, S González, R A Risques, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrenceM Sanchez-Cespedes, M Esteller, K Hibi, et al.
Oncogene|July 22, 1998
Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancersP Cairns, E Evron, K Okami, et al.
Carcinogenesis|January 18, 2006
The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 bindingS Mulero-Navarro, J M Carvajal-Gonzalez, M Herranz, et al.
Leukemia|November 5, 2004
Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasmsF Tort, S Hernández, S Beà, et al.
Cancer Research|March 8, 2000
Gene promoter hypermethylation in tumors and serum of head and neck cancer patientsM Sanchez-Cespedes, M Esteller, L Wu, et al.
Cancer Research|November 26, 1997
Frequent inactivation of PTEN/MMAC1 in primary prostate cancerP Cairns, K Okami, S Halachmi, et al.
Journal of Cellular Physiology|November 30, 2006
Multiple binding of methyl-CpG and polycomb proteins in long-term gene silencing eventsM R Matarazzo, M L De Bonis, M Strazzullo, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Oncogene|November 7, 2018
Correction: CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancerA Lujambio, A Portela, J Liz, et al.
Oncogene|September 6, 2016
Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogrammingO A Romero, S Verdura, M Torres-Diz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
K-ras and p16 aberrations confer poor prognosis in human colorectal cancerM Esteller, S González, R A Risques, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrenceM Sanchez-Cespedes, M Esteller, K Hibi, et al.
Oncogene|July 22, 1998
Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancersP Cairns, E Evron, K Okami, et al.
Carcinogenesis|January 18, 2006
The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 bindingS Mulero-Navarro, J M Carvajal-Gonzalez, M Herranz, et al.
Leukemia|November 5, 2004
Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasmsF Tort, S Hernández, S Beà, et al.
Cancer Research|March 8, 2000
Gene promoter hypermethylation in tumors and serum of head and neck cancer patientsM Sanchez-Cespedes, M Esteller, L Wu, et al.
Cancer Research|November 26, 1997
Frequent inactivation of PTEN/MMAC1 in primary prostate cancerP Cairns, K Okami, S Halachmi, et al.
Journal of Cellular Physiology|November 30, 2006
Multiple binding of methyl-CpG and polycomb proteins in long-term gene silencing eventsM R Matarazzo, M L De Bonis, M Strazzullo, et al.
Pageof 10